| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566730 Substituted aminoethers for the treatment of Alzheimer's disease |
| 07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
| 07/28/2009 | US7566699 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/28/2009 | US7566698 Extracted from plants such as Ningxia Lycium barbarum L. and/or Lycium chinense Mill; glucosyltransferases, cellulases; provitamin C with improved stability and bioavailability; ultraviolet damage protector; antiwrinkling; whitening |
| 07/28/2009 | US7566552 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/28/2009 | US7566539 Anti-CCR2 antibodies and methods of use therefor |
| 07/28/2009 | US7566535 Enhanced oligonucleotide-mediated nucleic acid sequence alteration |
| 07/28/2009 | US7566453 Methods for treating melanomas |
| 07/28/2009 | US7566450 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 07/28/2009 | CA2472008C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/28/2009 | CA2447329C 1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/28/2009 | CA2443012C Use of pyridoindolone derivatives for preparing medicines |
| 07/28/2009 | CA2399209C Process for preparation of indolopyrrolocarbazole derivative, intermediates in the preparation and process for preparation of the intermediates |
| 07/28/2009 | CA2370147C Piperidine-indole compounds having 5-ht6 affinity |
| 07/23/2009 | WO2009091531A2 Uniform-sized, multi-drug carrying and photosensitive liposomes for advance drug delivery |
| 07/23/2009 | WO2009091332A1 Methods for in vitro maturation of ovarian follicles |
| 07/23/2009 | WO2009091059A1 Composition for diagnosis, treatment or prevention of epilepsy |
| 07/23/2009 | WO2009091016A1 Condensed aminodihydrothiazine derivative |
| 07/23/2009 | WO2009091014A1 Phenyl acetamide derivative |
| 07/23/2009 | WO2009090976A1 Transmucosal therapeutic preparation for nasal obstruction |
| 07/23/2009 | WO2009061889A3 Grape polyphenolics for platelet and bacterial control |
| 07/23/2009 | WO2009055001A3 Methods of treating aging and methods of screening candidate agents therefor |
| 07/23/2009 | WO2007126363A8 Antisecretory protein for use in the treatment of compartment syndrome |
| 07/23/2009 | US20090186921 Azacyclic compounds |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186908 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/23/2009 | US20090186890 Pharmaceutical Formulation of Iressa Comprising a Water-Soluble Cellulose Derivative |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186867 Substituted Diketopiperazines As Oxytocin Antagonists |
| 07/23/2009 | US20090186856 Micronutrient phosphates as dietary and health supplements |
| 07/23/2009 | US20090186845 Interfering rna molecules |
| 07/23/2009 | US20090186843 RNA sequence-specific mediators of RNA interference |
| 07/23/2009 | US20090186833 Method for producing pectin hydrolysis products |
| 07/23/2009 | US20090186104 Herbal compositions for the treatment of mucosal lesions |
| 07/23/2009 | US20090186085 Methods and Apparatus For Determining Formulation Orientation of Multi-Layered Pharmaceutical Dosage Forms |
| 07/23/2009 | US20090186080 Methodology and apparatus for oral dual delivery of homeopathic products and non-homeopathic products |
| 07/23/2009 | US20090186074 Lipid vesicles derived from olive oil fatty acids |
| 07/23/2009 | US20090186073 Design of Delivery Vehicle Based On Rolling Model |
| 07/23/2009 | US20090186066 Method for production of chitosan-based films with enhanced cell adhering capacity, resulting product and applications |
| 07/23/2009 | US20090186065 Isolating and purifying cells for therapy |
| 07/23/2009 | US20090186037 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186029 Anticholesterol agents; generating an antibody which binds specifically to a C-terminal fragment of a vertebrate hedgehog polypeptide, comprising immunizing a mammalian subject with the C-terminal fragment |
| 07/23/2009 | US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof |
| 07/23/2009 | CA2712948A1 Phenylacetamide derivative |
| 07/23/2009 | CA2711655A1 Condensed aminodihydrothiazine derivative |
| 07/23/2009 | CA2711646A1 Methods for in vitro maturation of ovarian follicles |
| 07/22/2009 | EP2081028A1 Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness |
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080759A1 Gama-globin inducer |
| 07/22/2009 | EP2080751A1 Carboxylic acid derivative |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2080504A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 07/22/2009 | EP2079747A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 07/22/2009 | EP2079478A2 Materials and methods for treating and managing angiogenesis-mediated diseases |
| 07/22/2009 | EP2079469A2 Use of dipeptidyl peptidase iv inhibitors for preventing, delaying or reducing the occurance of edema |
| 07/22/2009 | EP2079468A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 07/22/2009 | EP2079444A2 Particles for cell targeting |
| 07/22/2009 | EP2006377A9 Novel tumor antigen peptides |
| 07/22/2009 | EP2006286A9 Isoxazole derivative and isothiazole derivative having inhibitory activity on 11 beta -hydroxysteroid dehydrogenase type i |
| 07/22/2009 | EP1531855A4 Treatment of bone disorders with skeletal anabolic drugs |
| 07/22/2009 | EP1503988B1 Fredericamycin derivatives |
| 07/22/2009 | EP1458413B1 Pharmaceutical compositions based on azetidine derivatives |
| 07/22/2009 | EP1453528B1 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | EP1299354B1 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 07/22/2009 | EP1292697B1 Method for preparing a physiologically active il-18 polypeptide |
| 07/22/2009 | EP1263719B1 N-deacetylthiocolchine derivatives and pharmaceutical compositions containing them |
| 07/22/2009 | EP1244455B1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 07/22/2009 | EP1220689B1 Medicament for the treatment of chronic fatigue syndrome associated with fibromyalgia and irritable bowel syndrome. |
| 07/22/2009 | EP1115390B1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |
| 07/22/2009 | CN101486677A 5HT2c receptor modulators |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516215C Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 07/22/2009 | CN100516059C Remedies |
| 07/22/2009 | CN100516047C Lactam compound |
| 07/22/2009 | CN100516041C Novel heteroaryl derivative |
| 07/22/2009 | CN100516040C Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516034C Inhibitors of aspartyl protease |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100515497C Liposomal delivery of vitamin E based compounds |
| 07/22/2009 | CN100515422C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 07/22/2009 | CN100515419C Substituted benzazoles and its application as inhibitors of Raf kinase |
| 07/21/2009 | USRE40861 4-Trimethylammonium-3-(nonylcarbamoyl)-aminobutyrate; hypoglycemic agents; antidiabetic agents; antiischemic agents; congestive heart failure; obesity |
| 07/21/2009 | US7563913 Compound and pharmaceutical composition |
| 07/21/2009 | US7563906 Indazole derivatives |
| 07/21/2009 | US7563822 active ingredient a 5-amidino-2-hydroxybenzenesulfonamide derivative or a pharmaceutical acceptable salt thereof; excellent inhibitory effect on mesangial cell proliferation and decreasing effect on urine protein excretion |
| 07/21/2009 | US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563586 Tetrodotoxin resistant membrane protein for use in pain management |